Cargando…

Characterization of patients with massive hypertrophic cardiomyopathy using contrast-enhanced magnetic resonance imaging: does contrast provide additional information?

Detalles Bibliográficos
Autores principales:	Chan, Raymond H, Hong, Susie, Haas, Tammy S, Feeney, Kristin, Lesser, John, Gibson, Michael C, Manning, Warren J, Maron, Barry J, Maron, Martin, Appelbaum, Evan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304824/ http://dx.doi.org/10.1186/1532-429X-14-S1-O99

Ejemplares similares

Characterization of tissue heterogeneity by contrast-enhanced cardiovascular magnetic resonance imaging is a powerful predictor of ventricular tachyarrhythmias on ambulatory holter ECG in hypertrophic cardiomyopathy
por: Harrigan, Caitlin J, et al.
Publicado: (2009)

Late gadolinium enhancement is compatible with advanced age in hypertrophic cardiomyopathy: implications for risk stratification of sudden death
por: Chan, Raymond H, et al.
Publicado: (2012)

Screening for hypertrophic cardiomyopathy: a cost analysis of echocardiography, cardiac magnetic resonance and genetic testing
por: Hauser, Thomas H, et al.
Publicado: (2009)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

What Causes Hypertrophic Cardiomyopathy?
por: Maron, Bradley A., et al.
Publicado: (2022)

Differing strategies for sudden death prevention in hypertrophic cardiomyopathy
por: Maron, Martin S, et al.
Publicado: (2023)

Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease?
por: Bonaventura, Jiri, et al.
Publicado: (2023)

Machine Learning for Predicting Heart Failure Progression in Hypertrophic Cardiomyopathy
por: Fahmy, Ahmed S., et al.
Publicado: (2021)

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy
por: Ghosh, Joydeep, et al.
Publicado: (2005)

Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy
por: Dass, Sairia, et al.
Publicado: (2012)

Effect of Left Ventricular Outflow Tract Obstruction on Left Atrial Mechanics in Hypertrophic Cardiomyopathy
por: Williams, Lynne K., et al.
Publicado: (2015)

Clinical Utility of Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
por: Maron, Martin S
Publicado: (2012)

Out With the Old and in With the New: Not So Fast in Hypertrophic Cardiomyopathy
por: Maron, Martin S.
Publicado: (2019)

Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2019)

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity
por: Bonaventura, Jiri, et al.
Publicado: (2023)

Future Role of New Negative Inotropic Agents in the Era of Established Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy
por: Maron, Barry J., et al.
Publicado: (2022)

Non-contrast T1rho CMR for hypertrophic cardiomyopathy
por: Wang, Chunhua, et al.
Publicado: (2015)

The necessity for full ventricular coverage with noncontrast T1 mapping in hypertrophic cardiomyopathy
por: Rowin, Ethan, et al.
Publicado: (2013)

Winter Is Coming: The Slippery Slope of Defining Disease and the Implications for Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2022)

Myocardial contrast echocardiography assessment of perfusion abnormalities in hypertrophic cardiomyopathy
por: Roldan, Paola, et al.
Publicado: (2022)

Preclinical alterations in cardiac energetics amongst sarcomere mutation carriers in hypertrophic cardiomyopathy
por: Lloyd, Rachael, et al.
Publicado: (2015)

Noncontrast T1 values do not correlate to clinically relevant variables in patients with hypertrophic cardiomyopathy
por: Rowin, Ethan, et al.
Publicado: (2013)

Altered intercellular communication and extracellular matrix signaling as a potential disease mechanism in human hypertrophic cardiomyopathy
por: Larson, Amy, et al.
Publicado: (2022)

Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
por: Hussain, Tarique, et al.
Publicado: (2013)

Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes
por: Maron, Bradley A., et al.
Publicado: (2021)

Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy
por: Sherrid, Mark V., et al.
Publicado: (2021)

Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy
por: Melacini, Paola, et al.
Publicado: (2010)

The quantification and role of diffuse myocardial fibrosis in familial dilated cardiomyopathy - an equilibrium contrast cmr study
por: Sado, Daniel M, et al.
Publicado: (2011)

T1 mapping in discrimination between hypertrophic and hypertensive cardiomyopathy
por: Hinojar, Rocio, et al.
Publicado: (2014)

Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy
por: Fahmy, Ahmed S., et al.
Publicado: (2022)

Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience
por: Weinstock, Jonathan, et al.
Publicado: (2016)

Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes
por: Maron, Bradley A., et al.
Publicado: (2022)

Identification of established arrhythmogenic right ventricular cardiomyopathy mutation in a patient with the contrasting phenotype of hypertrophic cardiomyopathy
por: Bainbridge, Matthew Neil, et al.
Publicado: (2017)

Echocardiographic profiles in hypertrophic cardiomyopathy: imaging beyond the septum and systolic anterior motion
por: Pandian, Natesa G, et al.
Publicado: (2015)

MRI with hepatobiliary contrast
por: Jhaveri, Kartik S
Publicado: (2015)

Potential of non-contrast stress T1 mapping for the assessment of myocardial injury in hypertrophic cardiomyopathy
por: Kosuge, Hisanori, et al.
Publicado: (2023)

Feline Hypertrophic Cardiomyopathy: A Spontaneous Large Animal Model of Human HCM
por: Freeman, Lisa M., et al.
Publicado: (2017)

Diffuse Myocardial Fibrosis detected by Multi-slice T(1) Mapping using Slice Interleaved T(1) (STONE) Sequence in Patients with Hypertrophic Cardiomyopathy
por: Kato, Shingo, et al.
Publicado: (2016)

Clinical significance of late gadolinium enhancement in pediatric patients with hypertrophic cardiomyopathy
por: Smith, Brandon M, et al.
Publicado: (2013)

Incremental predictive value of deep crypts in the basal inferoseptum in the setting of hypertrophic cardiomyopathy
por: Deva, Djeven P, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_583cbr33krok8e1ng30b450f1f